BioSpace News Archive

There is a notable increase in prevalence of chronic diseases world over and it is pushing the global ambulatory surgical centers market forward.

Novel drug delivery includes formulations, technologies, methods, and systems to transfer an active pharmaceutical ingredient in the body, as desired, in order to safely accomplish its therapeutic effect.

Withnanomolar potency against SARS-CoV-2, ASLAN003 is also being assessed for its potential as a novel therapeutic for COVID-19 and other viruses

JUD care, a leading high-tech enterprise in the field of smart medical and healthcare solutions, has kicked off its international partner program for its newly-launched portable ward sRoom, a revolutionary solution for patient isolation that enables medical staff to quickly set up emergency isolation rooms in different locations.

First-in-class antispastic drug candidate to reach clinical phase is published in the prestigious life science journal, Cell. Drug candidate MPH-220 could mean new hope for millions of patients suffering from spasticity.

Alnylam Pharmaceuticals, Inc. announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of lumasiran, an investigational RNAi therapeutic targeting the hydroxyacid oxidase 1 mRNA – encoding glycolate oxidase – in development for the treatment of primary hyperoxaluria type 1.

Renalytix AI plc, an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces that it will report its audited financial results for the full year ended June 30, 2020 on Tuesday, October 27 2020.

Two studies of AMI cardiogenic shock patients found higher survival when Impella was placed pre-PCI, compared to when Impella was placed after PCI.

Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases, today announced that Cantor Fitzgerald and Kristen Kluska will host a Management Fireside Chat Zoom Call on October 21 at 11 a.m. ET. Ocugen management, including Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder, Sanjay Subramanian, CFO, Dr. Mohamed Genead, Acting CMO and Ch

FSD Pharma Inc. (Nasdaq: HUGE) (“FSD Pharma” or the “Company”), today announced that it has entered into definitive agreements with investors for the purchase and sale of 4,318,179 Class B Subordinate Voting Shares of the Company (“Shares”) and warrants to purchase 3,454,543 Shares (collectively, the “Securities”) at a purchase price of US$2.20 per Share in a registered direct offering. The warrants will have an exercise price o